Tranexamic Acid in Sleeve Gastrectomy

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

January 2, 2023

Conditions
Tranexamic Acid Adverse Reaction
Interventions
OTHER

Transamine 200mg iv

In the intervention group, intravenous TXA (Transamine) 1000 mg dissolved in 100 mL 0.9% sodium chloride was administered intravenously within 10 minutes as a loading dose within the first 30 minutes at the end of the surgery. After the end of the loading dose, a maintenance dose of 120mg/hour TXA was infused in 500ml (60ml/hour) SF. The placebo group was given 100ml of saline in the first 30 minutes, followed by a maintenance dose of 60ml/hour of saline for 8 hours.

Trial Locations (1)

34732

Göztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadıköy

All Listed Sponsors
lead

Goztepe Prof Dr Suleyman Yalcın City Hospital

OTHER

NCT05696951 - Tranexamic Acid in Sleeve Gastrectomy | Biotech Hunter | Biotech Hunter